Advertisement

Supportive care in bone marrow transplantation: pulmonary complications

  • Stephen W. Crawford
Chapter
Part of the Cancer Treatment and Research book series (CTAR, volume 77)

Abstract

Overall, 40% to 60% of patients develop pulmonary disease at some time after marrow transplantation, and 24% to 40% require intensive care [1,2]. Characteristics such as increased HLA disparity with the donor source, high-dose conditioning regimens, active malignancy, and advanced age of the patient are associated with increased incidence of complications [3,4]. The incidence among patients who receive total body irradiation (TBI) for conditioning is higher than that of patients who receive only chemotherapy. Pneumonia as a clinical syndrome is the leading infectious cause of death, and until recently, Cytomegalovirus (CMV) was the most common cause of fatal pulmonary infection [5]. The incidence of some pulmonary infections, such as Pneumocystis carinii and perhaps bacterial pneumonia, has decreased due to the routine use of prophylactic antimicrobial agents. However, diffuse ‘idiopathic’ pulmonary injury continues, with mortality rate exceeding 60%. Newer understanding of idiopathic lung injury has led to the delineation of the recently coined ‘idiopathic pneumonia syndrome’ [6].

Keywords

Bone Marrow Transplantation Chronic GVHD Airflow Obstruction Total Lung Capacity Allogeneic Bone Marrow Transplantation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Afessa B, Tefferi A, Hoagland HC, Letendre L, Peters SG. Outcome of recipients of bone marrow transplants who require intensive-care unit support. Mayo Clin Proc 67:117–122, 1992.PubMedGoogle Scholar
  2. 2.
    O’Quin T, Moravec C. The critically ill bone marrow transplant patient. Semin Oncol Nursing 4:25–30,1988.CrossRefGoogle Scholar
  3. 3.
    Meyers JD, Flournoy N, Thomas ED. Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years’ experience. Rev Infect Dis 4:1119–1132, 1982.PubMedCrossRefGoogle Scholar
  4. 4.
    Weiner RS, Bortin MM, Gale RP, et al. Interstitial pneumonitis after bone marrow transplantation: assessment of risk factors. Ann Intern Med 104:168–175, 1986.PubMedGoogle Scholar
  5. 5.
    Ljungman P. Cytomegalovirus pneumonia: presentation, diagnosis and treatment. Semin Respir Infect, in press.Google Scholar
  6. 6.
    Clark JG, Hansen JA, Hertz MI, Parkman R, Jensen L, Peavy H. NHLBI Workshop Summary: Idiopathic pneumonia syndrome following bone marrow transplantation. Am Rev Respir Dis 147:1601–1606, 1992.Google Scholar
  7. 7.
    Chan CK, Hyland RH, Hutchen MA, et al. Small-airways disease in recipients of allogeneic bone marrow transplants. Medicine 66:327–340, 1987.PubMedCrossRefGoogle Scholar
  8. 8.
    Clark JC, Schwartz DA, Flournoy N, Sullivan KM, Crawford SW, Thomas ED. Risk factors for airflow obstruction in recipients of bone marrow transplants. Ann Intern Med 107:648–656, 1987.PubMedGoogle Scholar
  9. 9.
    Paz HL, Crilley P, Patchefsky A, Schiffman RL, Brodsky I. Bronchiolitis obliterans after autologous bone marrow transplantation. Chest 101:775–778, 1992.PubMedCrossRefGoogle Scholar
  10. 10.
    Meyers JD. Infection in bone marrow transplant recipients. Am J Med 81(Suppl 1A):27–38, 1986.PubMedCrossRefGoogle Scholar
  11. 11.
    van der Meer JWM, Guiot HFL, van den Broek PJ, van Furth R. Infections in bone marrow transplant recipients. Semin Hematol 21:123–140, 1984.PubMedGoogle Scholar
  12. 12.
    Hansen F. Hematopoietic growth and inhibitory factors in treatment of malignancy. A review. Acta Oncol 34:453–468, 1995.PubMedCrossRefGoogle Scholar
  13. 13.
    Dickout WJ, Chan CK, Hyland RH, et al. Prevention of acute pulmonary edema after bone marrow transplantation. Chest 92:303–309, 1987.PubMedCrossRefGoogle Scholar
  14. 14.
    Crawford SW, Hackman RC, Clark JG. Open lung biopsy diagnosis of diffuse pulmonary infiltrates after marrow transplantation. Chest 94:949–953, 1988.PubMedCrossRefGoogle Scholar
  15. 15.
    Goodrich JM, Bowden RA, Fisher L, Keller C, Schoch G, Meyers JD. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med 118:173–178, 1993.PubMedGoogle Scholar
  16. 16.
    Schmidt GM, Horak DA, Niland JC, Duncan SR, Forman SJ, Zaia JA. A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplantation. N Engl J Med 324:1005–1011,1991.PubMedCrossRefGoogle Scholar
  17. 17.
    Winston D, Ho W, Barioni K, et al. Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Ann Intern Med 118:179–184, 1993.PubMedGoogle Scholar
  18. 18.
    Ljungman P, Biron P, Bosi A, Cahn JY, Goldstone AH, Gorin NC, Link H, Messina C, Michallet M, Richard C. Cytomegalovirus interstitial pneumonia in autologous bone marrow transplant recipients. Infectious Disease Working Party of the European Group for Bone Marrow Transplantation. Bone Marrow Transplant 13:209–212, 1994.PubMedGoogle Scholar
  19. 19.
    McWhinney PH, Kibbler CC, Hamon MD, Smith OP, Gandhi L, Berger LA, Walesby RK, Hoffbrand AV, Prentice HG. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years’ experience. Clin Infect Dis 17:397–404, 1993.PubMedCrossRefGoogle Scholar
  20. 20.
    Kantrow SP, Hackman RC, Boeckh M, Myerson D, Crawford SW. Idiopathic pneumonia syndrome after bone marrow transplantation. Am Rev Respir Dis 149:A1030, 1994.Google Scholar
  21. 21.
    Carlson K, Backlund L, Smedmyr B, Oberg G, Simonsson B. Pulmonary function and complications subsequent to autologous bone marrow transplantation. Bone Marrow Transplant 14:805–811, 1994.PubMedGoogle Scholar
  22. 22.
    Ghalie R, Szidon JP, Thompson L, Nawas YN, Dolce A, Kaizer H. Evaluation of pulmonary complications after bone marrow transplantation: the role of pretransplant pulmonary function tests. Bone Marrow Transplant 10:359–365, 1992.PubMedGoogle Scholar
  23. 23.
    Crawford SW, Fisher L. Predictive value of pulmonary function tests before marrow transplantation. Chest 101:1257–1264, 1992.PubMedCrossRefGoogle Scholar
  24. 24.
    Springmeyer SC, Flournoy N, Sullivan KM, Storb R, Thomas ED. Pulmonary function changes in long-term survivors of allogeneic marrow transplantation. In Recent Advances in Bone Marrow Transplantation. New York: Alan R. Liss, Inc., 1983, pp. 343–353.Google Scholar
  25. 25.
    Springmeyer SC, Silvestri RC, Flournoy N, Kosanke W, Peterson DL, Huseby JS, Hudson LD, Storb R, Thomas ED. Pulmonary function of marrow transplant patients: I. Effects of marrow infusion, acute graft-versus-host-disease, and interstitial pneumonitis. Exp Hematol 12:805–810, 1984.PubMedGoogle Scholar
  26. 26.
    Sutedja TG, Apperley JF, Hughes JMB, Aber VR, Kennedy HG, Nunn P, Jones L, Hopper L, Goldman JM. Pulmonary function after bone marrow transplantation for chronic myeloid leukaemia. Thorax 43:163–169, 1988.PubMedCrossRefGoogle Scholar
  27. 27.
    Tait RC, Burnett AK, Robertson AG, McNee S, Riyami BMS, Carter R, Stevenson RD. Subclinical pulmonary function defects following autologous and allogeneic bone marrow transplantation: relationship to total body irradiation and graft-versus-host disease. Int J Radiat Oncol Biol Phys 20:1219–1227, 1991.PubMedCrossRefGoogle Scholar
  28. 28.
    Prince DS, Wingard JR, Sarai R, Santos GW, Wise RA. Longitudinal changes in pulmonary function following bone marrow transplantation. Chest 96:301–306, 1989.PubMedCrossRefGoogle Scholar
  29. 29.
    Link H, Reinhard U, Blaurock M, Ostendorf P. Lung function changes after allogeneic bone marrow transplantation. Thorax 41:508–512, 1986.PubMedCrossRefGoogle Scholar
  30. 30.
    Sorensen PG, Ernst P, Panduro J, Moller J. Reduced lung function in leukemia patients undergoing bone marrow transplantation. Scand J Haematol 32:253–257, 1984.PubMedGoogle Scholar
  31. 31.
    Depledge MH, Barrett A, Powles RL. Lung function after bone marrow grafting. Int J Radiat Oncol Biol Phys 9:145–151.Google Scholar
  32. 32.
    Hatta Y, Baba M, Aizawa S, Itoh T, Shida M, Yamazaki T, Sawada U, Ohshima T, Sawada S, Horie T. Changes of pulmonary function in patients treated with bone marrow transplantation after total body irradiation. Acta Haematol Jpn 53:923–930, 1990.Google Scholar
  33. 33.
    Badier M, Guillot C, Delpierre S, Vanuxem P, Blaise D, Maraninchi D. Pulmonary function changes 100 days and one year after bone marrow transplantation. Bone Marrow Transplant 12:457–461, 1993.PubMedGoogle Scholar
  34. 34.
    Jenney ME, Faragher EB, Jones PH, Woodcock A. Lung function and exercise in survivors of childhood leukemia. Med Pediat Oncol 24:222–230, 1995.CrossRefGoogle Scholar
  35. 35.
    Clark JG, Crawford SW, Madtes DK, Sullivan KM. Obstructive lung disease after allogeneic marrow transplantation: clinical presentation and course. Ann Intern Med 111:368–376, 1989.PubMedGoogle Scholar
  36. 36.
    Crawford SW, Pepe M, Lin D, Benedetti F, Deeg HJ. Abnormalities of pulmonary function tests after marrow transplantation predict non-relapse mortality. Am J Respir Crit Care Med 152:690–695, 1995.PubMedGoogle Scholar
  37. 37.
    Caterall JR, McCabe RE, Brooks, Remington JS. Open lung biopsy in patients with Hodgkin’s disease and pulmonary infiltrates. Am Rev Respir Dis 139:1274–1279, 1989.Google Scholar
  38. 38.
    McCabe RE, Brooks, Caterall JR, Remington JS. Open lung biopsy in patients with non-Hodgkin’s lymphoma and pulmonary infiltrates. Chest 96:319–324, 1989.PubMedCrossRefGoogle Scholar
  39. 39.
    Roth B, Crawford SW. Fungal infection with non-Hodgkin’s lymphoma. Chest 98:512, 1990.PubMedCrossRefGoogle Scholar
  40. 40.
    Navari RM, Sullivan KM, Springmeyer SC, Siegel MS, Meyers JD, Buckner CD, Sanders JE, Stewart PS, Clift RA, Fefer A, Storb R, Thomas ED. Mycobacterial infections in marrow transplant patients. Transplantation 36:509–513, 1983.PubMedCrossRefGoogle Scholar
  41. 41.
    Crawford SW, Schwartz DA, Petersen FB, Clark JG. Mechanical ventilation after marrow transplantation: risk factors and clinical outcome. Am Rev Respir Dis 137:682–687, 1988.PubMedGoogle Scholar
  42. 42.
    Schneiderman LJ, Arras JD. Counseling patients to counsel physicians on future care in the event of patient incompetence. Ann Intern Med 102:693–698, 1985.PubMedGoogle Scholar
  43. 43.
    Hauser MJ, Tabak J, Baier H. Survival of patients with cancer in a medical intensive care unit. Arch Intern Med 142:527–529, 1982.PubMedCrossRefGoogle Scholar
  44. 44.
    Snow RM, Miller WC, Rice DL, Ali MK. Respiratory failure in cancer patients. J Am Med Assoc 241:2039–2042, 1979.CrossRefGoogle Scholar
  45. 45.
    Ewer MS, Ali MK, Atta MS, Morice RC, Balakrishnan PV. Outcome of lung cancer patients requiring mechanical ventilation for pulmonary failure. J Am Med Assoc 256:3364–3366, 1986.CrossRefGoogle Scholar
  46. 46.
    Schuster DP, Marion JM. Precedents for meaningful recovery during treatment in a medical intensive care unit: outcome in patients with hematological malignancy. Am J Med 75:402–408, 1983.PubMedCrossRefGoogle Scholar
  47. 47.
    Peters SG, Meadows JA, Gracey DR. Outcome of respiratory failure in hematological malignancy. Chest 94:99–102, 1988.PubMedCrossRefGoogle Scholar
  48. 48.
    Faber-Langendoen K, Caplan AL, McGlave PB. Survival of adult bone marrow transplant patients receiving mechanical ventilation: a case for restricted use. Bone Marrow Transplant 12:501–507, 1993.PubMedGoogle Scholar
  49. 49.
    Crawford SW, Schwartz DA, Petersen FB, Clark JG. Mechanical ventilation after marrow transplantation: risk factors and clinical outcome. Am Rev Respir Dis 137:682–687, 1988.PubMedGoogle Scholar
  50. 50.
    Crawford SW, Petersen FB. Long-term survival from respiratory failure after marrow transplantation. Am Rev Respir Dis 145:510–514, 1992.PubMedGoogle Scholar
  51. 51.
    Denardo SJ, Oye RK, Bellamy PE. Efficacy of intensive care for bone marrow transplant patients with respiratory failure. Crit Care Med 17:4–6, 1989.PubMedCrossRefGoogle Scholar
  52. 52.
    Bojko T, Notterman DA, Greenwald BM, DeBruin WJ, Magid MS, Godwin T. Acute hypoxemic respiratory failure in children following bone marrow transplantation: an outcome and pathologic study. Crit Care Med 23:755–759, 1995.PubMedCrossRefGoogle Scholar
  53. 53.
    Rosenfeld GD, Crawford SW. Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence-based guidelines. Annals Intern Med 125:625–633, 1996.Google Scholar
  54. 54.
    Krowka MJ, Roscnow EC, Hoagland HC. Pulmonary complications of bone marrow transplantation. Chest 87:237–246, 1985.PubMedCrossRefGoogle Scholar
  55. 55.
    Wingard JR, Mellits ED, Sostrin MB, Chen DY-H, Burns WH, Santos GW, Vriesendorp HM, Beschorner WE, Sarai R. Interstitial pneumonia after allogeneic marrow transplantation. Medicine (Baltimore) 67:175–186, 1988.Google Scholar
  56. 56.
    Hackman RC. Lower respiratory tract. In Sale GE, Shulman HM (eds), The Pathology of Bone Marrow Transplantation. New York: Masson, 1984, pp. 156–170.Google Scholar
  57. 57.
    Appelbaum FR, Sullivan KM, Buckner CD, et al. Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation. J Clin Oncol 5:1340–1347, 1987.PubMedGoogle Scholar
  58. 58.
    Sloane JP, Depledge MH, Powles RL, Morgenstern GR, Trickey BS, Dady PJ. Histopathology of the lung after bone marrow transplantation. J Clin Pathol 36:546–554, 1983.PubMedCrossRefGoogle Scholar
  59. 59.
    Beschorner WE, Sarai R, Hutchin GM, et al. Lymphocytic bronchitis associated with graft-versus-host disease in recipients of bone marrow transplants. N Engl J Med 299:1030–1036, 1978.PubMedCrossRefGoogle Scholar
  60. 60.
    Crawford SW, Hackman RC. Clinical course of idiopathic pneumonia after marrow transplantation. Am Rev Respir Dis 147:1393–1400, 1993.PubMedGoogle Scholar
  61. 61.
    Crawford SW, Bowden RA, Hackman RC, Gleaves CA, Meyers JD, Clark JG. Rapid detection of cytomegalovirus pulmonary infection by bronchoalveolar lavage and centrifugation culture. Ann Intern Med 108:180–185, 1988.PubMedGoogle Scholar
  62. 62.
    Robbins RA, Linder J, Stahl MG, Thompson AB, Haire W, Kessinger A, Armitage JO, Arneson M, Woods G, Vaughn WP, Rennard SI. Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. Am J Med 87:511–518, 1989.PubMedCrossRefGoogle Scholar
  63. 63.
    Jules-Elysee K, Stover DE, Yahalom J, White DA, Gulati SC. Pulmonary complications in lymphoma patients treated with high-dose therapy and autologous bone marrow transplantation. Am Rev Respir Dis 146:485–491, 1992.PubMedGoogle Scholar
  64. 64.
    DeLassence A, Fleury-Feith J, Escudicr E, Beaunc J, Bernaudin J-E, Cordonnier C. Alveolar hemorrhage: diagnostic criteria and results in 194 immunocompromised hosts. Am J Respir Crit Care Med 151:151–163, 1995.Google Scholar
  65. 65.
    Agusti C, Ramirez J, Picado C, Xaubet A, Carreras E, Ballesler E, Torres A, Batlochia C, Rodriquez-Roisin R. Diffuse alveolar hemorrhage in allogeneic bone marrow transplantation: a post-mortem study. Am J Respir Crit Care Med 151:1006–1006, 1995.PubMedGoogle Scholar
  66. 66.
    Sisson JH, Thompson AB, Anderson JR, Robbins RA, Spurzem JR, Spence PR, Reed EC, Armitage JO, Vose JM, Arneson MA, Vaughn WP, Rennard SI. Airway inflammation predicts diffuse alveolar hemorrhage during bone marrow transplantation in patients with Hodgkin’s disease. Am Rev Respir Dis 146:439–443, 1992.PubMedGoogle Scholar
  67. 67.
    Metcalf JP, Rennard SI, Reed EC, Haire WD, Sisson JH, Walter T, Robbins RA. Corticosteroids as adjunctive therapy for diffuse alveolar hemorrhage associated with bone marrow transplantation. Am J Med 96:327–334, 1994.PubMedCrossRefGoogle Scholar
  68. 68.
    Chao NJ, Duncan SR, Long GD, Horning SJ, Blume KG. Corticosteroid therapy for diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. Ann Intern Med 114:145–146, 1991.PubMedGoogle Scholar
  69. 69.
    Schultz KR, Green GJ, Wensley D, Sargent MA, Magee JF, Spinelli JJ, Pritchard S, Davis JH, Rogers PC, Chan KW, et al. Obstructive lung disease in children after allogeneic bone marrow transplantation. Blood 84:3212–3220, 1994.PubMedGoogle Scholar
  70. 70.
    Holland HK, Wingard JR, Beschorner WE, Sarai R, Santos GW. Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG. Blood 72:621–627, 1988.PubMedGoogle Scholar
  71. 71.
    Witherspoon RP, Storb R, Ochs HD, et al. Recovery of antibody production in human allogeneic marrow graft recipients: influence of time post-transplantation, presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment. Blood 58:360–368, 1981.PubMedGoogle Scholar
  72. 72.
    Sargent MA, Cairns RA, Murdoch MJ, Nadel HR, Wensley D, Schultz KR. Obstructive lung disease in children after allogeneic bone marrow transplantation: evaluation with high-resolution CT. Am J Roentgen 164:693–696, 1995.Google Scholar
  73. 73.
    Urbanski SJ, Kossakowska AE, Curtis J, et al. Idiopathic small airways pathology in patients with graft-versus-host disease following allogeneic bone marrow transplantation. Am J Surg Pathol 11:965–971, 1987.PubMedCrossRefGoogle Scholar
  74. 74.
    Glanville AR, Baldwin JC, Burke CM, et al. Obliterative bronchiolitis after heart-lung transplantation: apparent arrest by augmented immunosuppression. Ann Intern Med 107:300–304, 1987.PubMedGoogle Scholar
  75. 75.
    Sullivan KM, Kopecky KJ, Jocom J, Fisher L, Buckner CD, Meyers JD, Counts GW, Bowden RA, Petersen FB, Witherspoon RP, Budinger MD, Schwartz RS, Appelbaum FR, Clift RA, Hansen JA, Sanders JE, Thomas ED, Storb R. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med 323:705–712, 1990.PubMedCrossRefGoogle Scholar
  76. 76.
    Crawford SW, Bowden RA, Hackman RC, Gleaves CA, Meyers JD, Clark JG. Rapid detection of cytomegalovirus pulmonary infection by bronchoalveolar lavage and centrifugation culture. Ann Intern Med 108:180–185, 1988.PubMedGoogle Scholar
  77. 77.
    Emanuel D, Peppard J, Stover D, Gold J, Armstrong D, Hammerling U. Rapid immunodiagnosis of cytomegalovirus pneumonia by bronchoalveolar lavage using human and murine monoclonal antibodies. Ann Intern Med 104:476–481, 1986.PubMedGoogle Scholar
  78. 78.
    Weiss SM. Hert RC, Gianola FJ, Clark JG, Crawford SW. Complications of fiberoptic bronchoscopy in thrombocytopenic patients. Chest 104:1025–1028, 1993.PubMedCrossRefGoogle Scholar
  79. 79.
    Springmeyer SC, Silvestri RC, Sale GE, et al. The role of transbronchial biopsy for the diagnosis of diffuse pneumonias in immunocompronised marrow transplant recipients. Am Rev Respir Dis 126:763–765, 1982.PubMedGoogle Scholar
  80. 80.
    Nishio JN, Lynch JP. Fiberoptic bronchoscopy in the immunocompromised host: the significance of a ‘nonspecific’ transbronchial biopsy. Am Rev Respir Dis 121:307–312, 1980.PubMedGoogle Scholar
  81. 81.
    Haponik EF, Summer WR, Terry PB, Wang KP. Clinical decision making with transbronchial lung biopsies: the value of nonspecific histologic examination. Am Rev Respir Dis 125:524–529, 1982.PubMedGoogle Scholar
  82. 82.
    Ellis ME, Spence D, Bouchama A, Antonius J, Bazarbashi M, Khougeer F, De Vol EB. Open lung biopsy provides a higher and more specific diagnostic yield compared to bronchoalveolar lavage in immunocompromised patients. Scand J Infect Dis 27:157–162, 1995.PubMedCrossRefGoogle Scholar
  83. 83.
    Bove P, Ranger W, Pursel S, Glover J, Bove K, Bendick P. Evaluation of outcome following open lung biopsy. Am Surg 60:564–570, 1994.PubMedGoogle Scholar
  84. 84.
    Wagner JD, Stahler C, Knox S, Brinton M, Knecht B. Clinical utility of open lung biopsy for undiagnosed pulmonary infiltrates. Am J Surg 164:104–108, 1992.PubMedCrossRefGoogle Scholar
  85. 85.
    Rubin JW. Video-assisted thoracic surgery: the approach of choice for selected diagnosis and therapy. Eur J Cardio-Thorac Surg 8:431–435, 1993.CrossRefGoogle Scholar
  86. 86.
    Schwarz CD, Lenglinger F, Eckmayr J, Schauer N, Hartl P, Mayer KH. VATS (video-assisted thoracic surgery) of undefined pulmonary nodules. Preoperative evaluation of video-endoscopic resectability. Chest 106:1570–1574, 1994.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Stephen W. Crawford

There are no affiliations available

Personalised recommendations